Doctronic
PrivateLast Round
Series B
Mar 24, 2026
Est. Valuation
$85M
Total Funding Raised
$65M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Doctronic operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series B round in March 2026.
Doctronic is a healthcare AI company that provides an AI-native platform for 24/7 personalized medical consultations, symptom triage, and virtual visits with licensed physicians.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Telemedicine, NLP & Conversational AI, Patient Engagement
Business Model
B2C
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Doctronic Comparables
Compare Doctronic with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hyro | 66% | |
| K Health | 62% | |
| Nolla Health | 60% |
For institutional investors. Book with your work email.
Doctronic Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 24, 2026 | ||||
| Series A | Sep 15, 2025 | ||||
| Seed | Apr 18, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Doctronic Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mantis Venture Capital | Series B, Series A |
| Union Square Ventures | Series B, Series A, Seed |
| Davidovs Venture Capital | Series B, Series A |
| Tusk Venture Partners | Seed, Series B, Series A |
| Abstract Ventures | Series B |
| HF0 Residency | Seed, Series A |
| Seven Stars | Series B, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Grew 26% QoQ, from 57 to 72 employees.
- Jul 28, 2026
Grew 20% QoQ, from 56 to 67 employees.
For institutional investors. Book with your work email.
Doctronic Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Doctronic's valuation, stock price, and market status.
Is Doctronic a public or private company?
Doctronic is a private company.
What is the current stock price of Doctronic?
Doctronic is a private company, so its shares have no public market price. Caplight tracks Doctronic's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Doctronic worth (valuation)?
Doctronic's valuation is estimated at $85.0M based on funding round data.
Can I buy Doctronic stock?
Doctronic shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Doctronic's last funding round?
Doctronic's most recent funding round was Series B on March 24, 2026.
Who are the main investors in Doctronic?
Key investors in Doctronic include Union Square Ventures, Abstract Ventures, Abstract Ventures, Lightspeed Venture Partners.
Will Doctronic IPO soon?
No public IPO plans have been announced for Doctronic.
How can I track Doctronic secondary market activity?
Caplight tracks bids, offers, and trades in Doctronic's shares on secondary markets.